Tuesday, November 6, 2018

Sanofi and Regeneron's Dupixent gets more positive feedback from U.S. FDA - companies

The U.S. Food & Drug Administration (FDA) regulator gave more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.
https://ift.tt/2zyfi6K support@endlesssupplies.biz (Endless Supplies .Biz) November 06, 2018 at 01:03AM
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)